1
Nov
2022

HTL Biotechnology

Exhibitor at CPHI Frankfurt 2022 stand 110D50, API
About Us

HTL is a leading biotech and industrial player in the development and production of innovative, pharmaceutical-grade biopolymers that are used by leading pharmaceutical and medical device companies to transform the lives of millions of patients in multiple therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology, and urology.

A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined its innovative functional biopolymer platform that has enabled it to produce "customised", pharmaceutical grade products for customers worldwide for over 25 years.

HTL is at the forefront of innovation in the biopolymer industry to meet tomorrow's medical needs by creating new types of biopolymers and chemical modifications, while exploring the untapped potential of biopolymers in innovative applications such as bioprinting or drug delivery.‍

HTL conducts its production activities in fully compliant cGMP facilities.

To find out more about HTL: www.htlbiotech.com

  • FR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 110D50, API

Products Featured at CPHI Frankfurt 2022

  • Hyaluronan / hyaluronic acid by HTL

    Product Hyaluronan / hyaluronic acid by HTL

    Hyaluronic acid, also known as Hyaluronan, is a biopolymer that is naturally present in the human body. It has been used for many years as a raw material or ingredient for medical products in various fields including ophthalmology, orthopaedics and dermatology.
    HTL produces injectable grade Hyaluro...
  • Chondroitin by fermentation by HTL

    Product Chondroitin by fermentation by HTL

    While most Chondroitin sulfate on the market is of animal origin, HTL is developing a new source of Chondroitin of non-animal origin with the use of fermentation. Chondroitin sulfate can then be obtained by sulfation. 

    Characteristics and benefits of Chondroitin by fermentation:  ...
  • Heparosan by HTL

    Product Heparosan by HTL

    HTL is developing Heparosan, a promising raw material for the design of innovative medical devices. Under license, HTL will be the sole producer of medical grade, high molecular weight Heparosan by fermentation (20 kDa to 2MDa). Safe for use in humans, Heparosan is an endogenous GlycosAminoGlycan with...
  • Functionalized GlycosAminoGlycan Derivatives

    Product Functionalized GlycosAminoGlycan Derivatives

    HTL offers the tailor-made development of functionalized derivatives of Glycosaminoglycans, such as modified Hyaluronic Acid, Heparosan and Chondroitin. Developing new functionalities by chemical modification allows the optimization of existing uses of these biopolymers, but also opens opportunities for n...